Celebrating our Donors Generosity
Dr. Martin & Barbara Zweig: Make $1 million gift to Mount Sinai in support of Cancer Research
Dr. Martin Zweig is known to many as one of the most successful investment advisors of our time. With a $1 million gift to Mount Sinai Medical Center, Dr. Zweig and his wife, Barbara, now have the distinction of being Humanitarians in the Society of Mount Sinai. The gift, presented to the hospital in January, will be used to support Mount Sinai’s mission to provide cutting-edge research by funding the medical center’s Community Clinical Oncology Program (CCOP).
A renowned money manager, author and newsletter writer, Dr. Zweig was a frequent guest on the weekly PBS television series “Wall Street Week” for 30 years. Barbara Zweig is a retired Wall Street executive and sits on the Board of Overseers of the Mailman School of Public Health at Columbia University in New York.
“We know that cancer is the second leading cause of death in the United States and we are committed to helping find a cure for this disease,” Dr. Zweig said. “We are very proud to fund life-saving cancer research through Mount Sinai’s CCOP.”
Mount Sinai is the only hospital in Florida to participate in the adult CCOP, a grant funded program created by the National Cancer Institute that enables 61 major research centers across the country to join in clinical trials that test the most advanced new cancer treatments. The medical center will recognize the Zweig’s generosity by establishing the Zweig Family Foundation Endowed Chair, Director of Cancer Research. The chair currently is held by Rogerio Lilenbaum, M.D., CCOP’s principal investigator.
“We are honored that the Zweigs have entrusted Mount Sinai with such a significant contribution,” said Michael M. Adler, chairman of the hospital’s board of trustees. “They are to be commended for their philanthropic support and for their decision to direct their gift to cancer research.”
As residents of Fisher Island, the Zweigs have long believed in supporting local charities. Already part of the Mount Sinai family, Dr. and Mrs. Zweig joined the Founders Club, the hospital’s most time-honored philanthropic group in 2004.
“Because Mount Sinai is a private independent not-for-profit teaching hospital, we rely on the generosity of philanthropists to help us remain on the leading edge of healthcare and provide the best care possible for our patients,” said Mark H. Hildebrandt, president of Mount Sinai Medical Center Foundation. “We truly appreciate the Zweig’s generosity and their decision to support cancer research.”
As a result of their ground-breaking research, CCOP researchers have helped to prove the value of Tamoxifen in preventing breast cancer, defined the best treatment options for leukemias and lymphomas, and discovered the benefits of new drugs in the treatment of rare diseases.
“With this gift, Martin and Barbara Zweig are helping to assure that we continue to provide life-saving care to countless patients for generations to come,” said Steven D. Sonenreich, Mount Sinai’s president and chief executive officer. “We are extremely grateful for their foresight and support.”